Safety and Potential Risks of Prolonged Use of Proton Pump Inhibitors
Journal Title: Гастроентерологія - Year 2014, Vol 1, Issue 51
Abstract
Article deals with the use of proton pump inhibitors in gastroenterology. We considered the impact of proton pump inhibitors on of a variety of processes in the body, such as the absorption of vitamins and minerals, osteoporosis and fractures, the risks of infection, tumors, renal pathology. Separately, the question is raised of omeprazole interaction with other drugs.
Authors and Affiliations
S. M. Tkach
Keywords
Related Articles
- EP ID EP225045
- DOI -
- Views 74
- Downloads 0
Experience in the Use of Psychocorrection Therapy in the Comprehensive Treatment of Patients with Gastroesophageal Reflux Disease Combined with Dysfunction of the Biliary System
Nowadays, due to the rapid increase in the number of stress factors, it is especially important to use psychotherapy and psychopharmacotherapy in the combination treatment of patients with diseases of the gastrointestina...
Current State of Antibiotic Resistance to Helicobacter pylori and its Clinical Significance
The article presents an analysis of published data in recent years on the development and prevalence of Helicobacter pylori resistance to various antibiotics, which are used for the eradication of this microorganism. The...
Value of Fecal Calprotectin in Rotavirus Infection in Infants
The article presents results of a study of calprotectin level in faeces in infants with rotavirus. The aim of this study was to determine the value of fecal calprotectin concentration fluctuations in rotavirus infection...
Modern approaches to the treatment of irritable bowel syndrome through the prism of the “intestine — brain” axis
Irritable bowel syndrome is one of the most common functional disorders of the gastrointestinal tract. Significant role in its occurrence is played by the interaction between the factors of the environment and the indivi...
Enzyme Preparations of the Pancreas without Enteric Coating: Whether they are Used Today?
Introduction. For the treatment of exocrine pancreatic insufficiency (EPI) it is recommended enzyme replacement therapy with high-dose enteric-coated preparations. In this regard, the question arises about the rationale...